95 related articles for article (PubMed ID: 9308250)
1. Effects of interferon alpha on myeloma cells: mechanisms of differential responsiveness.
Jelinek DF; Arora T
Curr Top Microbiol Immunol; 1997; 224():261-8. PubMed ID: 9308250
[No Abstract] [Full Text] [Related]
2. Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis.
Liu P; Oken M; Van Ness B
Leukemia; 1999 Mar; 13(3):473-80. PubMed ID: 10086739
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
4. Human myeloma cell apoptosis induced by interferon-alpha.
Otsuki T; Yamada O; Sakaguchi H; Tomokuni A; Wada H; Yawata Y; Ueki A
Br J Haematol; 1998 Nov; 103(2):518-29. PubMed ID: 9827928
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule.
Puthier D; Thabard W; Rapp M; Etrillard M; Harousseau J; Bataille R; Amiot M
Br J Haematol; 2001 Feb; 112(2):358-63. PubMed ID: 11167829
[TBL] [Abstract][Full Text] [Related]
6. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
[TBL] [Abstract][Full Text] [Related]
7. Upregulated production of IL-6, but not IL-10, by interferon-alpha induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells.
Usui E; Nishii K; Katayama N; Lorenzo V F; Chen F; Monma F; Otsuki T; Shiku H
Hematol J; 2004; 5(6):505-12. PubMed ID: 15570293
[TBL] [Abstract][Full Text] [Related]
8. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
Cheung WC; Van Ness B
Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
[TBL] [Abstract][Full Text] [Related]
9. Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression.
Jelinek DF; Aagaard-Tillery KM; Arendt BK; Arora T; Tschumper RC; Westendorf JJ
J Clin Invest; 1997 Feb; 99(3):447-56. PubMed ID: 9022078
[TBL] [Abstract][Full Text] [Related]
10. Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.
Walters DK; French JD; Arendt BK; Jelinek DF
Oncogene; 2003 Jun; 22(23):3598-607. PubMed ID: 12789268
[TBL] [Abstract][Full Text] [Related]
11. IL-6-receptor-mediated growth inhibition by all-trans retinoic acid but not by interferon-alpha in human myeloma cells.
Pulkki K; Neva M; Koskela K; Ollikainen H; Remes K; Pelliniemi TT
Ann N Y Acad Sci; 1995 Jul; 762():457-8. PubMed ID: 7668556
[No Abstract] [Full Text] [Related]
12. Signaling, drugs and apoptosis of myeloma cells.
Carroll M; Abrams CS
Cancer Biol Ther; 2004 Feb; 3(2):195-6. PubMed ID: 14976430
[No Abstract] [Full Text] [Related]
13. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.
Radaeva S; Jaruga B; Hong F; Kim WH; Fan S; Cai H; Strom S; Liu Y; El-Assal O; Gao B
Gastroenterology; 2002 Apr; 122(4):1020-34. PubMed ID: 11910354
[TBL] [Abstract][Full Text] [Related]
14. Growth control mechanisms in multiple myeloma.
Hawley RG; Berger LC
Leuk Lymphoma; 1998 May; 29(5-6):465-75. PubMed ID: 9643560
[TBL] [Abstract][Full Text] [Related]
15. Oncogene expression is modulated by recombinant human interferon-beta in human breast-cancer cells.
Sica G; Angelucci C; Marini L; Milazzo F; Donini S
Int J Cancer; 1996 Jul; 67(3):441-6. PubMed ID: 8707422
[TBL] [Abstract][Full Text] [Related]
16. [Effects of IFN-alpha combined with IL-6 on cell growth and related genes expression and apoptosis of bone marrow cells from CGL patients].
Chen H; Tang L; Peng X; Luo Z; Luo S; Tan W
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):341-4. PubMed ID: 11877000
[TBL] [Abstract][Full Text] [Related]
17. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.
Bharti AC; Donato N; Aggarwal BB
J Immunol; 2003 Oct; 171(7):3863-71. PubMed ID: 14500688
[TBL] [Abstract][Full Text] [Related]
18. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.
Jourdan M; Zhang XG; Portier M; Boiron JM; Bataille R; Klein B
J Immunol; 1991 Dec; 147(12):4402-7. PubMed ID: 1753108
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
20. FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression.
Firme L; Bush AB
BMC Cell Biol; 2003 Dec; 4():17. PubMed ID: 14656381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
